Loading...
•
Dec 31, 2023
Phibro Q2 2024 Earnings Report
Phibro Animal Health Corporation reported a net sales increase of 2% and a net income decrease of 82% compared to the same quarter last year.
Key Takeaways
Phibro Animal Health Corporation reported second quarter results with a net sales increase of 2% to $249.9 million. However, net income decreased by 82% to $1.3 million, and diluted earnings per share decreased by $0.15 to $0.03.
Net sales increased by 2% to $249.9 million.
Net income decreased by $5.9 million to $1.3 million.
Diluted earnings per share decreased by $0.15 to $0.03.
Adjusted EBITDA decreased by 5% to $29.5 million.
Phibro
Phibro
Phibro Revenue by Segment
Revenue by Segment
Animal Health Revenue
CapyFin.comMFAs and Other Revenue
CapyFin.comNutritional Specialties Revenue
CapyFin.comVaccines Revenue
CapyFin.comMineral Nutrition Revenue
CapyFin.comPerformance Products Revenue
CapyFin.com Forward Guidance
Phibro Animal Health Corporation updated its fiscal year 2024 financial guidance, reflecting recent developments including expenses for Brazil employment taxes, additional foreign currency losses, acquisition-related expenses, and related effects on the provision for income taxes.
Revenue & Expenses
Visualization of income flow from segment revenue to net income